Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Atlanta | 370 Studies

Clinical Trials LymphomaAtlanta

Lymphoma Clinical Trials in Atlanta

Find 370 clinical trials for lymphoma near Atlanta, Georgia. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 370 trials

CompletedA Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)The overall purpose of the study is to determine if MEDI-551, when used in combination with salvage chemotherapy, Ifosfamide-carboplatin-etoposide (ICE) or…NCT01453205·Birmingham, Alabama and 80 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingDuvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary SyndromeThis phase I trial identifies the best dose, possible benefits, and/or side effects of duvelisib in combination with nivolumab in treating patients with stage IIB-IVB mycosis…NCT04652960·Phoenix, Arizona and 16 others

TerminatedGRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseThe purpose of this study is to assess the impact and safety of itacitinib in combination with calcineurin inhibitor (CNI)-based interventions for the prophylaxis of…NCT03320642·Aurora, Colorado and 16 others

RecruitingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyThis phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral T-cell lymphoma…NCT06724237·Birmingham, Alabama and 164 others

CompletedA Phase I/II Trial of VR-CHOP in Lymphoma PatientsThis is an open-label (doctors and patients know which drug will be given), single center, phase 1/2 clinical trial.NCT00634179·Atlanta, Georgia

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors…NCT03155620·Birmingham, Alabama and 171 others

CompletedA Study Of Panobinostat In Children With Refractory Hematologic MalignanciesThis study is for patients with relapsed or refractory Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Hodgkin's Disease (HD) or Non-Hodgkin's Lymphoma (NHL).NCT01321346·Los Angeles, California and 19 others

CompletedBortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular LymphomaThis randomized phase I/II trial studies the side effects and the best dose of temsirolimus when given together with bortezomib, rituximab, and dexamethasone and to see how well…NCT01381692·Denver, Colorado and 10 others

CompletedStudy Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)This open-label Phase 1 study will evaluate the safety, PK, and antitumor activity of modified T cells (JCAR017) administered to adult patients with relapsed or refractory B-cell…NCT02631044·Birmingham, Alabama and 13 others

CompletedPhase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental AreaTo evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).NCT01542034·Birmingham, Alabama and 35 others

RecruitingSIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)This is a 3-part study.NCT05303519·Birmingham, Alabama and 60 others

CompletedBrentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell LymphomaThis partially randomized phase II trial studies how well brentuximab vedotin or crizotinib and combination chemotherapy works in treating patients with newly diagnosed stage…NCT01979536·Birmingham, Alabama and 153 others

CompletedTotal Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic DiseasesIn this study, patients will receive a myeloablative preparative regimen consisting of fludarabine and total body irradiation (TBI), followed by a T cell replete, mobilized…NCT01336712·Atlanta, Georgia

TerminatedA Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant PairsThis is an open-label, multicenter, prospective pilot study of CDX-301 with or without plerixafor as a stem cell mobilizer for allogeneic transplantation (stem cells that come…NCT02200380·Los Angeles, California and 7 others

RecruitingAZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaThis is a Phase 1/2, global multicentre, open-label, single-arm, dose escalation and dose optimization study of surovatamig (AZD0486) to evaluate the safety, tolerability, and…NCT06137118·Birmingham, Alabama and 81 others

CompletedA Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin LymphomaThis was a Phase 2 clinical trial to evaluate the safety and efficacy of duvelisib as a monotherapy in participants with indolent non-Hodgkin lymphoma (iNHL) (follicular lymphoma…NCT01882803·Los Angeles, California and 68 others

CompletedPK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma PatientsThis is a study for the outcome and safety of individualized busulfan dosing with cyclophosphamide and etoposide for patients preparing for a stem cell transplant to treat…NCT00948090·Birmingham, Alabama and 41 others

Active not recruitingImatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaThis randomized phase III trial studies how well imatinib mesylate works in combination with two different chemotherapy regimens in treating patients with newly diagnosed…NCT03007147·Birmingham, Alabama and 225 others

Active not recruitingLarotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well larotrectinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with NTRK fusions…NCT03213704·Birmingham, Alabama and 123 others

CompletedSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantThis randomized phase III trial is studying how well Caphosol rinse works in preventing mucositis in young patients undergoing autologous or donor stem cell transplant.NCT01305200·Arcadia, California and 34 others

PreviousPage 5 of 19Next

Other Conditions in Atlanta

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia